News & Events

Vivoryon Therapeutics Announces Financial Results for the First Quarter of 2021 and Provides Corporate Update

HALLE (SAALE) / MUNICH, GERMANY, June 25, 2021 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) today announced financial results and provided a corporate update for […]

Vivoryon Therapeutics Reschedules Reporting of 1st Quarter 2021 and Provides Update for Annual General Meeting of Shareholders

HALLE (SAALE) / MUNICH, GERMANY, May 31, 2021 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) announced today that the publication of the 1st quarter 2021 […]

Vivoryon Therapeutics Announces Notice of its Annual General Meeting of Shareholders to be Held on June 28, 2021

HALLE (SAALE) / MUNICH, GERMANY, May 17, 2021 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) invites all shareholders to Vivoryon’s annual general meeting of shareholders to […]

Vivoryon Therapeutics N.V. Reports Full Year 2020 Financial Results

English conference call and webcast today, April 30th at 3:00 pm CEST (09:00 am EDT) a HALLE (SAALE) / MUNICH, GERMANY, April 30, 2021 – Vivoryon Therapeutics N.V. […]

Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021

HALLE (SAALE) / MUNICH, GERMANY, 14 April 2021 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) announced today that the publication of the Full Year 2020 […]

Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer’s Disease Treatment Options with Leaders and Experts on April 15th, 2021

HALLE (SAALE) / MUNICH, GERMANY, 1 April 2021 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) announced today that it will host a virtual event […]

Extraordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.

All proposed resolutions approved with large majority             HALLE (SAALE) / MUNICH, GERMANY, 12 March 2021 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) announced today […]

Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO

 HALLE (SAALE) / MUNICH, GERMANY, 29 January 2021 – the Board of Directors (Board) of Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) announced today that […]

Vivoryon Therapeutics N.V. new ISIN code

HALLE (SAALE) / MUNICH, Germany, 06 January 2021 – in connection with the conversion into an N.V., a public company under the laws of the Netherlands (naamloze […]